Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2367 of 6351
-
Could a formula closer to breast milk boost baby development?
Knowledge-focused CompletedThis study aims to learn about a newly developed infant formula that adds two special ingredients found in breast milk (human milk oligosaccharides, HMOs) and improves other nutrients. We will compare the effects of this new formula, a currently available standard formula, and br…
Sponsor: Heilongjiang Feihe Dairy Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New COPD drug itepekimab tested for Long-Term safety in 700 patients
Disease control OngoingThis is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments. The primary purpose of this study is to evaluate safety and to…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Iron pills before scoliosis surgery may cut transfusions and boost recovery
Disease control Recruiting nowThis study is a randomized controlled trial of preoperative oral iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in …
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Peer navigators aim to boost cancer trial enrollment for hispanic kids
Knowledge-focused Recruiting nowCOMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform …
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New hope for tough blood cancers: first human trial of GLB-001 begins
Disease control Recruiting nowStudy GLB-001-01 is a first-in-human (FIH), Phase 1, open-label, dose escalation and expansion clinical study of GLB-001 in participants with relapsed or refractory acute myeloid leukemia (R/R AML) or in participants with relapsed or refractory higher-risk myelodysplastic syndrom…
Phase 1 • Sponsor: GluBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could beans and lentils beat red meat for a healthier heart?
Disease control CompletedThe goal of this clinical trial is to investigate the effects of replacing red meat with pulses, on cardiometabolic health and gut microbiome in individuals with unhealthy habits and sedentary lifestyles at high risk for cardiovascular diseases. The main questions it aims to answ…
Sponsor: Paola Vitaglione • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
No-Needle liver check: spleen scan may spot silent danger
Diagnosis Recruiting nowThe goal of this observational study is to assess non-invasive tools' efficacy in predicting portal hypertension-related complications in individuals with advanced chronic liver disease. The main question it aims to answer are: \- what are the cut-off values for non-invasive tes…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Arthritis drug repurposed to fight stem cell transplant complication
Disease control Recruiting nowThis is a randomized, single-center phase 3 clinical trial without blinding. Iguratimod, as a rheumatoid arthritis medication, is used to treat autoimmune diseases such as Sjögren's syndrome. It has acceptable side effects, good clinical availability, and is cost-effective. The i…
Phase 3 • Sponsor: Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New ear scanner could slash unnecessary antibiotics in kids
Diagnosis OngoingA pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.
Sponsor: PhotoniCare, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New supplement aims to shield menopausal brains from cognitive decline
Prevention OngoingThis is a proof-of-concept phase 2 clinical trial to investigate the safety and effect of the phytoestrogenic supplement PhytoSERM on regional brain metabolism by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in peri- and postmenopausal women. The inve…
Phase 2 • Sponsor: Roberta Brinton • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Can a blood thinner protect Kids' hearts after kawasaki? small study aims to find out
Disease control Recruiting nowBased on a population pharmacokinetic model-based dose optimization study, a 15 mg-equivalent, age-, and bodyweight-adjusted dosing regimen for Chinese children with giant coronary artery aneurysms after Kawasaki disease was proposed. This single-center, single-arm, pilot study a…
Phase 4 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 26, 2026 14:36 UTC
-
New heart stent aims to cut blood thinner time, lower bleeding risk
Disease control Recruiting nowThe objective of this post marketing observational registry is to evaluate clinical outcomes (safety and performance) in an all-comers population with coronary artery disease (CAD) treated with the Polymer Free Sirolimus Eluting Coronary Stent Vivo ISAR and planned for an abbrevi…
Sponsor: Translumina Therapeutics Pvt Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:10 UTC
-
Tiny eye implant aims to lower glaucoma pressure
Disease control OngoingGlaucoma is the second most common cause of blindness in the world, second only to cataracts. The purpose of this study is to assess adverse events (AEs) and changes in disease activity in participants with open-angle glaucoma (OAG) receiving the XEN45 Glaucoma Treatment System (…
Phase 4 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could one antibiotic dose replace three after jaw surgery?
Prevention Recruiting nowOrthognathic surgery describes a group of procedures aimed at correcting developmental or acquired deformities of the jaws and facial skeleton. The goal of these procedures is to improve speech, jaw and dental function, aesthetics, and symptoms of sleep apnea. This is accomplishe…
Phase 4 • Sponsor: Abdul El-Rabbany • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
5G Radiation's hidden impact on skin revealed in new trial
Knowledge-focused Recruiting nowThe current 5G waves used on the daily life are ranging from 410 MHz to 7125 MHz and are called FR1. The next deployed 5G waves will be FR2, from 24.45 GHz to 52.6 GHz. Our project targets the 27.5 GHz frequency, as it will be used in both Europe and the USA. Recent studies have …
Sponsor: Prof. Olivier Gaide, MD-PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New bacteria slurry takes on poop transplants for stubborn gut infection
Disease control CompletedInvestigating four different treatment of MTC or FMT
Phase 1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Sound waves to the brain could ease long COVID fatigue
Symptom relief Recruiting nowThe objective of the present study is to demonstrate treatment efficacy of transcranial pulse stimulation for patients with Post-COVID-19 related neurological symptoms (fatigue, cognitive deficits, mood deterioration). Fatigue, as measured by the Fatigue Impact Scale (FIS), will …
Sponsor: Medical University of Vienna • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
A simple screening program could transform cancer aftercare
Knowledge-focused OngoingThis study proposes to evaluate the process and outcome of an implementation program designed to implement nurse-led symptom distress screening and referral into routine cancer care clinics. Specifically, using a stepped-wedge cluster randomized controlled trial, This study aim t…
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New combo therapy may offer lasting pain control for facial nerve condition
Symptom relief CompletedTrigeminal neuralgia is a severe facial pain condition that significantly impacts quality of life. While the standard medication, carbamazepine, provides relief, it is often associated with side effects and rapid pain recurrence upon discontinuation. This randomized clinical tria…
Phase 2 • Sponsor: Karbala University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Cancer drug T-DXd safety tracked in ongoing rollover study
Disease control Recruiting nowThis open-label, multicenter, rollover study will provide continued treatment for participants deriving benefit from different therapies received in studies sponsored by Daiichi Sankyo, Inc. (DS) or DS/Astra Zeneca (AZ)-sponsored study (eg. DS8201-A-J101, DS8201-A-U201, DS8201-A-…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC